KLK7 and thyroid gland papillary carcinoma: For instance, lncRNA FOXD2-AS1 controlled the miR-485-5p/KLK7 axis to enhance papillary thyroid cancer progression, which revealed that FOXD2-AS1 acted as a ceRNA to increase the expression of KLK7 through sponging miR-485-5p in papillary thyroid cancer [37].